Microbiome Therapeutics Global Market Report 2022

Microbiome Therapeutics Global Market Report 2022 – By Product (Probiotics, Prebiotics, Symbiotics, and Other Products), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, and Other Applications), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, and E-commerce Stores) – Market Size, Trends, And Global Forecast 2022-2026

Name: Microbiome Therapeutics Global Market Report 2022
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Microbiome Therapeutics Global Market Report 2022

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

The microbiome therapeutics market consists of sales of microbiome therapeutics and related services by entities (organizations, sole traders, partnership) which are used to treat and prevent various diseases. The microbiome comprises the genetic material within a microbiota which is an entire collection of microorganisms found in and on all multicellular organisms.

The main products of microbiome therapeutics are probiotics, prebiotics, symbiotics, and other products. Probiotics are a combination of live beneficial bacteria and/or yeasts that naturally live in the body. The various distribution channels involved are hospital pharmacies, drug stores, retail pharmacies, and e-commerce stores. The applications included are inflammatory bowel disease, diabetes, multiple sclerosis, rheumatoid arthritis, and other applications.

The global microbiome therapeutics market size is expected to grow from $0.29 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 34.7%. The global microbiome therapeutics market size is expected to grow to $1 billion in 2026 at a compound annual growth rate (CAGR) of 26.4%.

The rising prevalence of obesity is expected to propel the growth of the microbiome therapeutics market. Sedentary lifestyles, busy work lives, and unhealthy food choices are gradually becoming the leading causes of obesity globally. Growing urbanization and busy lifestyles are leading to an increasing preference for packaged and processed foods and physical inactivity. Microbiome therapeutics help prevent and treat diabetes by regulating sugar levels. For instance, in 2022, according to the UK Parliament, a survey found that men are more likely than women to be overweight or obese (68.2% of men, 60.4% of women). People aged 45–74 are most likely to be overweight or obese. Therefore, the rising prevalence of obesity is driving the growth of microbiome therapeutics.

Increased research and development is a key trend gaining popularity in the microbiome therapeutics market. Companies operating in the microbiome therapeutics market are focused on developing new innovations to increase their market share. For instance, in March 2022, Microbiotica, a UK-based company, raised $67 million in a Series B round to push two microbiome-based lead assets through phase 1b trials, slated to start this year.

In April 2022, Xbiome Inc., a China-based artificial intelligence microbiome therapeutics startup, acquired a clinical-stage M201 program from Assembly Biosciences, Inc. for an undisclosed amount. This acquisition reflects Xbiome’s commitment as one of the leaders in the rising field of microbiome therapeutics. Assembly Biosciences, Inc. is a US-based clinical-stage biotechnology company.

Major players in the microbiome therapeutics market are Seres Therapeutics, Enterome Bioscience, Rebiotix, Microbiome Therapeutics, and Ritter Pharmaceuticals.

North America was the largest region in the microbiome therapeutics market in 2021. The regions covered in the global microbiome therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the microbiome therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The global microbiome therapeutics market is segmented -

1) By Product: Probiotics, Prebiotics, Symbiotics, and Others

2) By Application: Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, and Others

3) By Distribution Channel: Hospital Pharmacies, Drug stores, Retail Pharmacies, and E-commerce stores

Book your 30 minutes free consultation with our research experts

1. Executive Summary

2. Microbiome Therapeutics Market Characteristics

3. Microbiome Therapeutics Market Size And Growth

3.1. Global Microbiome Therapeutics Historic Market, 2016 - 2021, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Microbiome Therapeutics Forecast Market, 2021-2026F, 2031F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Microbiome Therapeutics Market Segmentation

4.1. Global Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Probiotics

Prebiotics

Symbiotics

Other Products

4.2. Global Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Inflammatory Bowel Disease

Diabetes

Multiple Sclerosis

Rheumatoid Arthritis

Others

4.3. Global Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Hospital Pharmacies

Drug stores

Retail Pharmacies

E-commerce stores

5. Microbiome Therapeutics Market Regional And Country Analysis

5.1. Global Microbiome Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

5.2. Global Microbiome Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6. Asia-Pacific Microbiome Therapeutics Market

6.1. Asia-Pacific Microbiome Therapeutics Market Overview

6.2. Asia-Pacific Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6.3. Asia-Pacific Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6.4. Asia-Pacific Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7. China Microbiome Therapeutics Market

7.1. China Microbiome Therapeutics Market Overview

7.2. China Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

7.3. China Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

7.4. China Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

8. India Microbiome Therapeutics Market

8.1. India Microbiome Therapeutics Market Overview

8.2. India Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8.3. India Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8.4. India Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. Japan Microbiome Therapeutics Market

9.1. Japan Microbiome Therapeutics Market Overview

9.2. Japan Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9.3. Japan Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9.4. Japan Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

10. Australia Microbiome Therapeutics Market

10.1. Australia Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

10.2. Australia Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

10.3. Australia Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Indonesia Microbiome Therapeutics Market

11.1. Indonesia Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11.2. Indonesia Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11.3. Indonesia Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. South Korea Microbiome Therapeutics Market

12.1. South Korea Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12.2. South Korea Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12.3. South Korea Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Western Europe Microbiome Therapeutics Market

13.1. Western Europe Microbiome Therapeutics Market Overview

13.2. Western Europe Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13.3. Western Europe Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13.4. Western Europe Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. UK Microbiome Therapeutics Market

14.1. UK Microbiome Therapeutics Market Overview

14.2. UK Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14.3. UK Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14.4. UK Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Germany Microbiome Therapeutics Market

15.1. Germany Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15.2. Germany Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15.3. Germany Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. France Microbiome Therapeutics Market

16.5. France Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16.6. France Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16.7. France Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Eastern Europe Microbiome Therapeutics Market

17.1. Eastern Europe Microbiome Therapeutics Market Overview

17.2. Eastern Europe Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17.3. Eastern Europe Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17.4. Eastern Europe Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. Russia Microbiome Therapeutics Market

18.1. Russia Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18.2. Russia Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18.3. Russia Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. North America Microbiome Therapeutics Market

19.1. North America Microbiome Therapeutics Market Overview

19.2. North America Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19.3. North America Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19.4. North America Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. USA Microbiome Therapeutics Market

20.1. USA Microbiome Therapeutics Market Overview

20.2. USA Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20.3. USA Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20.4. USA Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. South America Microbiome Therapeutics Market

21.1. South America Microbiome Therapeutics Market Overview

21.2. South America Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21.3. South America Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21.4. South America Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. Brazil Microbiome Therapeutics Market

22.1. Brazil Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22.2. Brazil Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22.3. Brazil Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. Middle East Microbiome Therapeutics Market

23.1. Middle East Microbiome Therapeutics Market Overview

23.2. Middle East Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23.3. Middle East Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23.4. Middle East Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Africa Microbiome Therapeutics Market

24.1. Africa Microbiome Therapeutics Market Overview

24.2. Africa Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24.3. Africa Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24.4. Africa Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Microbiome Therapeutics Market Competitive Landscape And Company Profiles

25.1. Microbiome Therapeutics Market Competitive Landscape

25.2. Microbiome Therapeutics Market Company Profiles

25.2.1. Seres Therapeutics

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Enterome Bioscience

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Rebiotix

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. MicroBiome Therapeutics

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Ritter Pharmaceuticals

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Microbiome Therapeutics Market

27. Microbiome Therapeutics Market Trends And Strategies

28. Microbiome Therapeutics Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2016-2021, $ Billion

Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion

Table 3: Global Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 4: Global Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 5: Global Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 6: Global Microbiome Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 7: Global Microbiome Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 8: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 9: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 10: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 11: China, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 12: China, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 13: China, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 14: India, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 15: India, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 16: India, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 17: Japan, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 18: Japan, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 19: Japan, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 20: Australia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 21: Australia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 22: Australia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 23: Indonesia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 24: Indonesia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 25: Indonesia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 26: South Korea, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 27: South Korea, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 28: South Korea, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 29: Western Europe, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 30: Western Europe, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 31: Western Europe, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 32: UK, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 33: UK, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 34: UK, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 35: Germany, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 36: Germany, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 37: Germany, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 38: France, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 39: France, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 40: France, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 41: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 42: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 43: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 44: Russia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 45: Russia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 46: Russia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 47: North America, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 48: North America, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 49: North America, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 50: USA, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 51: USA, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 52: USA, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 53: South America, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 54: South America, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 55: South America, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 56: Brazil, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 57: Brazil, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 58: Brazil, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 59: Middle East, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 60: Middle East, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 61: Middle East, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 62: Africa, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 63: Africa, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 64: Africa, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Table 65: Seres Therapeutics Financial Performance

Table 66: Enterome Bioscience Financial Performance

Table 67: Rebiotix Financial Performance

Table 68: MicroBiome Therapeutics Financial Performance

Table 69: Ritter Pharmaceuticals Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2016-2021, $ Billion

Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion

Figure 3: Global Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 4: Global Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 5: Global Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 6: Global Microbiome Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 7: Global Microbiome Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 8: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 9: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 10: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 11: China, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 12: China, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 13: China, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 14: India, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 15: India, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 16: India, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 17: Japan, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 18: Japan, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 19: Japan, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 20: Australia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 21: Australia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 22: Australia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 23: Indonesia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 24: Indonesia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 25: Indonesia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 26: South Korea, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 27: South Korea, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 28: South Korea, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 29: Western Europe, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 30: Western Europe, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 31: Western Europe, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 32: UK, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 33: UK, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 34: UK, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 35: Germany, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 36: Germany, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 37: Germany, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 38: France, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 39: France, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 40: France, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 41: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 42: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 43: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 44: Russia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 45: Russia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 46: Russia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 47: North America, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 48: North America, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 49: North America, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 50: USA, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 51: USA, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 52: USA, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 53: South America, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 54: South America, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 55: South America, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 56: Brazil, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 57: Brazil, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 58: Brazil, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 59: Middle East, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 60: Middle East, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 61: Middle East, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 62: Africa, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 63: Africa, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 64: Africa, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion

Figure 65: Seres Therapeutics Financial Performance

Figure 66: Enterome Bioscience Financial Performance

Figure 67: Rebiotix Financial Performance

Figure 68: MicroBiome Therapeutics Financial Performance

Figure 69: Ritter Pharmaceuticals Financial Performance

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Prenatal Testing & Newborn Screening Global Market Report 2024 – By Diagnostic Type (Non-Invasive, Invasive), By Technology (Screening Technology, Diagnostic Technology), By End user (Hospitals, Diagnostic centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Medical Billing Outsourcing Global Market Report 2024 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Revenue Cycle Management Software Global Market Report 2024 – By Product (Integrated, Standalone), By Function (Claim And Denial, Medical Biling And Coding, Patient Insurance Eligibility Check, Payment Remittance, Electronic Health Record (EHR), Clinical Documentation Improvement (CDI), Other Functions), By Deployment (Web based, On premise, Cloud based) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Payer Services Global Market Report 2024 –By Outsourcing Services (Business Process Outsourcing Services, Knowledge Process Outsourcing Services, Information Technology Outsourcing Services), By Application (Revenue Cycle Management, Healthcare Reimbursement, Medical Billing Outsourcing, Other Applications), By End-User (Public Payers, Private Payers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)

View Report

Fertility Services Global Market Report 2024 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the microbiome therapeutics market?

The microbiome therapeutics market consists of sales of microbiome therapeutics and related services which are used to treat and prevent various diseases such as Type 2 diabetes, Obesity, C. difficile infection and primary hyperoxyurea request a sample here

How will the microbiome therapeutics market drivers and restraints affect microbiome therapeutics market dynamics? What forces will shape the microbiome therapeutics industry going forward?

The microbiome therapeutics market growth is aided by rising prevalence of obesity. However, some microbiome therapeutics market restraints include lack of proper regulations also inhibit investors to invest in microbiome therapeutics request a sample here

What is the forecast market size of the microbiome therapeutics market?

The microbiome therapeutics market forecast is expected to reach $1.28 billion in 2022 at a compound annual growth rate of 14.2%. request a sample here

How is the microbiome therapeutics market segmented?

request a sample here

Which region has largest share, and what is the market size and growth by geography according to the microbiome therapeutics global market report?

For more detail on this, request a sample here.

Who are the key players of the global microbiome therapeutics market?

Top competitors in the microbiome therapeutics market are Seres Therapeutics, Enterome Bioscience, Rebiotix, MicroBiome Therapeutics and Ritter Pharmaceuticals. request a sample here.

What are the key trends in the global microbiome therapeutics market?

Major trends influencing the microbiome therapeutics market include use of phage therapy as their core technology due to its effectiveness in killing disease-causing bacteria in the human body. request a sample here.

What are the major opportunities in the microbiome therapeutics market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global microbiome therapeutics market, request a sample here.

How does the microbiome therapeutics market relate to the overall economy and other similar markets?

request a sample here.